Urolithiasis Management Devices Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2030

Description

Persistence Market Research has recently released an in-depth analysis of the Urolithiasis Management Devices Market, providing critical insights into market dynamics, growth drivers, challenges, and emerging trends. This report presents exclusive data and statistics forecasting the market's trajectory from 2023 to 2030, offering valuable perspectives for stakeholders in the healthcare industry.

The global urolithiasis management devices market is forecast to expand at a CAGR of 5.1% and thereby increase from a value of US$1.6 Bn in 2023, to US$2.2 Bn by the end of 2030.

Key Insights:

Urolithiasis Management Devices Market Size (2023 Estimate): USD 1.6 Billion
Projected Market Value (2030 Forecast): US$ 2.2 Billion
Global Market Growth Rate (CAGR 2023 to 2030): 5.1%
Historical Market Growth Rate (CAGR 2018 to 2022): 4.1%

Urolithiasis Management Devices Market - Report Scope:

The urolithiasis management devices market encompasses a wide range of medical devices and technologies aimed at the diagnosis, treatment, and prevention of urinary tract stones. These devices include lithotripters, ureteroscopes, stone retrieval devices, stents, and stone management consumables. The market is driven by the increasing prevalence of urolithiasis, advancements in minimally invasive surgical techniques, and the growing demand for outpatient stone management procedures. Moreover, technological innovations, such as the integration of robotics and imaging modalities, are revolutionizing urolithiasis treatment, offering patients safer and more effective therapeutic options.

Market Growth Drivers:

The global urolithiasis management devices market is primarily fueled by the rising incidence of urinary tract stones worldwide. Factors such as sedentary lifestyles, dietary habits, and environmental factors contribute to the formation of kidney stones, driving the demand for advanced treatment modalities. Minimally invasive procedures, such as extracorporeal shock wave lithotripsy (ESWL) and ureteroscopy, are preferred by patients due to their reduced post-operative complications and shorter recovery times. Furthermore, the advent of laser lithotripsy and the development of disposable ureteroscopes are expanding the treatment options available to urolithiasis patients, fostering market growth.

Market Restraints:

Despite favorable market conditions, the urolithiasis management devices market faces challenges related to reimbursement policies, healthcare infrastructure, and patient awareness. Inadequate reimbursement for certain urolithiasis procedures and devices limits patient access to advanced treatments, particularly in emerging markets. Moreover, disparities in healthcare infrastructure, particularly in rural and underserved areas, hinder timely diagnosis and treatment of urolithiasis, exacerbating patient outcomes and treatment costs. Furthermore, limited patient awareness about urolithiasis prevention strategies and treatment options impedes early intervention and disease management, prolonging patient suffering and healthcare expenditures.

Market Opportunities:

The global urolithiasis management devices market is poised to capitalize on emerging opportunities in telemedicine, digital health, and patient-centric care models. With the proliferation of telehealth platforms and remote monitoring technologies, healthcare providers can deliver timely consultations and follow-ups to urolithiasis patients, enhancing treatment adherence and outcomes. Moreover, digital health solutions, such as mobile applications and wearable devices, empower patients to track their symptoms, medication adherence, and lifestyle modifications, facilitating personalized disease management and preventive interventions. By harnessing the power of technology and patient engagement, stakeholders in the urolithiasis management devices market can optimize healthcare delivery, improve patient satisfaction, and reduce overall healthcare costs.

Key Questions Addressed in the Report:

Which regions are expected to drive the growth of the urolithiasis management devices market in the coming years?
What are the primary factors driving the adoption of urolithiasis management devices and technologies?
How will evolving treatment guidelines and technological advancements influence market dynamics?
Who are the key players shaping the competitive landscape of the urolithiasis management devices market?
What strategies are market participants employing to gain a competitive edge and expand their market presence?

Competitive Landscape and Business Strategies:

Major players in the global urolithiasis management devices market, including Olympus Corporation, Boston Scientific Corporation, and Cook Medical LLC, prioritize innovation and strategic partnerships to maintain their market leadership. These companies invest heavily in research and development to develop next-generation urolithiasis management devices with enhanced efficacy, safety, and patient comfort. Moreover, strategic collaborations with healthcare providers and academic institutions enable market players to conduct clinical trials, validate product performance, and generate real-world evidence supporting the adoption of their devices. By focusing on product innovation, clinical evidence generation, and market expansion initiatives, leading players can capitalize on emerging opportunities and address unmet needs in the urolithiasis management devices market.

Key Companies Profiled:

Allengers
Boston Scientific
BD
Cook Medical
ConMed
DirexGroup
Dornier MedTech
KARL STORZ
Potent Optotronic
HealthTronics
Lumenis
Olympus
Richard Wolf
Siemens Healthcare

Urolithiasis Management Devices Market Segmentation:

By Treatment Type:

Extracorporeal Shock Wave Lithotripsy (ESWL)
Percutaneous Nephrolithotomy
Intracorporeal Lithotripsy
Others

By Product Type:

Lithotripters
Ureteroscopes

By End User:

Hospitals and Clinics
Ambulatory Surgical Centers (ASCs)

By Region:

North America
Europe
East Asia
South Asia & Oceania
Latin America
Middle East & Africa

Product Code: PMRREP33964

1. Executive Summary

1.1. Global Urolithiasis Management Devices Market Snapshot, 2023 and 2030
1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations

2. Market Overview

2.1. Market Scope and Definition
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunity
- 2.2.4. Challenges
- 2.2.5. Key Trends
2.3. Treatment Type Lifecycle Analysis
2.4. Urolithiasis Management Devices Market: Value Chain
- 2.4.1. List of Raw Material Supplier
- 2.4.2. List of Manufacturers
- 2.4.3. List of Distributors
- 2.4.4. List of Applications
- 2.4.5. Profitability Analysis
2.5. Porter Five Force's Analysis
2.6. Geopolitical Tensions: Market Impact
2.7. Macro-Economic Factors
- 2.7.1. Global Sectorial Outlook
- 2.7.2. Global GDP Growth Outlook
- 2.7.3. Global Parent Market Overview
2.8. Forecast Factors - Relevance and Impact
2.9. Regulatory and Technology Landscape

3. Global Urolithiasis Management Devices Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

3.1. Key Highlights
- 3.1.1. Market Volume (Units) Projections
- 3.1.2. Market Size and Y-o-Y Growth
- 3.1.3. Absolute $ Opportunity
3.2. Market Size (US$ Mn) Analysis and Forecast
- 3.2.1. Historical Market Size Analysis, 2013-2016
- 3.2.2. Current Market Size Forecast, 2018-2026
3.3. Global Urolithiasis Management Devices Market Outlook: Treatment Type
- 3.3.1. Introduction / Key Findings
- 3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Treatment Type, 2018 - 2022
- 3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment Type, 2023 - 2030
  - 3.3.3.1. Extracorporeal Shock Wave Lithotripsy (ESWL)
  - 3.3.3.2. Percutaneous Nephrolithotomy
  - 3.3.3.3. Intracorporeal Lithotripsy
  - 3.3.3.4. Others
3.4. Market Attractiveness Analysis: Treatment Type
3.5. Global Urolithiasis Management Devices Market Outlook: Product Type
- 3.5.1. Introduction / Key Findings
- 3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product Type, 2018 - 2022
- 3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
  - 3.5.3.1. Lithotripters
  - 3.5.3.2. Ureteroscopes
3.6. Market Attractiveness Analysis: Product Type
3.7. Global Urolithiasis Management Devices Market Outlook: End User
- 3.7.1. Introduction / Key Findings
- 3.7.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End User, 2018 - 2022
- 3.7.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
  - 3.7.3.1. Hospitals and Clinics
  - 3.7.3.2. Ambulatory Surgical Centers (ASCs)
3.8. Market Attractiveness Analysis: End User

4. Global Urolithiasis Management Devices Market Outlook: Region

4.1. Key Highlights
4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022
4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030
- 4.3.1. North America
- 4.3.2. Europe
- 4.3.3. East Asia
- 4.3.4. South Asia and Oceania
- 4.3.5. Latin America
- 4.3.6. Middle East & Africa (MEA)
4.4. Market Attractiveness Analysis: Region

5. North America Urolithiasis Management Devices Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

5.1. Key Highlights
5.2. Pricing Analysis
5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 5.3.1. By Country
- 5.3.2. By Treatment Type
- 5.3.3. By Product Type
- 5.3.4. By End User
5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 5.4.1. U.S.
- 5.4.2. Canada
5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment Type, 2023 - 2030
- 5.5.1. Extracorporeal Shock Wave Lithotripsy (ESWL)
- 5.5.2. Percutaneous Nephrolithotomy
- 5.5.3. Intracorporeal Lithotripsy
- 5.5.4. Others
5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
- 5.6.1. Mechanical
- 5.6.2. Ureteroscopes
5.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 5.7.1. Hospitals and Clinics
- 5.7.2. Ambulatory Surgical Centers (ASCs)
5.8. Market Attractiveness Analysis

6. Europe Urolithiasis Management Devices Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

6.1. Key Highlights
6.2. Pricing Analysis
6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 6.3.1. By Country
- 6.3.2. By Treatment Type
- 6.3.3. By Product Type
- 6.3.4. By End User
6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 6.4.1. Germany
- 6.4.2. France
- 6.4.3. U.K.
- 6.4.4. Italy
- 6.4.5. Spain
- 6.4.6. Russia
- 6.4.7. T rkiye
- 6.4.8. Rest of Europe
6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment Type, 2023 - 2030
- 6.5.1. Extracorporeal Shock Wave Lithotripsy (ESWL)
- 6.5.2. Percutaneous Nephrolithotomy
- 6.5.3. Intracorporeal Lithotripsy
- 6.5.4. Others
6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
- 6.6.1. Mechanical
- 6.6.2. Ureteroscopes
6.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 6.7.1. Hospitals and Clinics
- 6.7.2. Ambulatory Surgical Centers (ASCs)
6.8. Market Attractiveness Analysis

7. East Asia Urolithiasis Management Devices Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 7.3.1. By Country
- 7.3.2. By Treatment Type
- 7.3.3. By Product Type
- 7.3.4. By End User
7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 7.4.1. China
- 7.4.2. Japan
- 7.4.3. South Korea
7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment Type, 2023 - 2030
- 7.5.1. Extracorporeal Shock Wave Lithotripsy (ESWL)
- 7.5.2. Percutaneous Nephrolithotomy
- 7.5.3. Intracorporeal Lithotripsy
- 7.5.4. Others
7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
- 7.6.1. Mechanical
- 7.6.2. Ureteroscopes
7.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 7.7.1. Hospitals and Clinics
- 7.7.2. Ambulatory Surgical Centers (ASCs)
7.8. Market Attractiveness Analysis

8. South Asia & Oceania Urolithiasis Management Devices Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 8.3.1. By Country
- 8.3.2. By Treatment Type
- 8.3.3. By Product Type
- 8.3.4. By End User
8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 8.4.1. India
- 8.4.2. Southeast Asia
- 8.4.3. ANZ
- 8.4.4. Rest of South Asia & Oceania
8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment Type, 2023 - 2030
- 8.5.1. Extracorporeal Shock Wave Lithotripsy (ESWL)
- 8.5.2. Percutaneous Nephrolithotomy
- 8.5.3. Intracorporeal Lithotripsy
- 8.5.4. Others
8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
- 8.6.1. Mechanical
- 8.6.2. Ureteroscopes
8.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 8.7.1. Hospitals and Clinics
- 8.7.2. Ambulatory Surgical Centers (ASCs)
8.8. Market Attractiveness Analysis

9. Latin America Urolithiasis Management Devices Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 9.3.1. By Country
- 9.3.2. By Treatment Type
- 9.3.3. By Product Type
- 9.3.4. By End User
9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 9.4.1. Brazil
- 9.4.2. Mexico
- 9.4.3. Rest of Latin America
9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment Type, 2023 - 2030
- 9.5.1. Extracorporeal Shock Wave Lithotripsy (ESWL)
- 9.5.2. Percutaneous Nephrolithotomy
- 9.5.3. Intracorporeal Lithotripsy
- 9.5.4. Others
9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
- 9.6.1. Mechanical
- 9.6.2. Ureteroscopes
9.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 9.7.1. Hospitals and Clinics
- 9.7.2. Ambulatory Surgical Centers (ASCs)
9.8. Market Attractiveness Analysis

10. Middle East & Africa Urolithiasis Management Devices Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 10.3.1. By Country
- 10.3.2. By Treatment Type
- 10.3.3. By Product Type
- 10.3.4. By End User
10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 10.4.1. GCC
- 10.4.2. Egypt
- 10.4.3. South Africa
- 10.4.4. Northern Africa
- 10.4.5. Rest of Middle East & Africa
10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment Type, 2023 - 2030
- 10.5.1. Extracorporeal Shock Wave Lithotripsy (ESWL)
- 10.5.2. Percutaneous Nephrolithotomy
- 10.5.3. Intracorporeal Lithotripsy
- 10.5.4. Others
10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
- 10.6.1. Mechanical
- 10.6.2. Ureteroscopes
10.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 10.7.1. Hospitals and Clinics
- 10.7.2. Ambulatory Surgical Centers (ASCs)
10.8. Market Attractiveness Analysis

11. Competition Landscape

11.1. Market Share Analysis, 2022
11.2. Market Structure
- 11.2.1. Competition Intensity Mapping By Market
- 11.2.2. Competition Dashboard
- 11.2.3. Apparent Product Capacity
11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
- 11.3.1. Allengers
  - 11.3.1.1. Overview
  - 11.3.1.2. Segments and Product
  - 11.3.1.3. Key Financials
  - 11.3.1.4. Market Developments
  - 11.3.1.5. Market Strategy
- 11.3.2. Boston Scientific
  - 11.3.2.1. Overview
  - 11.3.2.2. Segments and Product
  - 11.3.2.3. Key Financials
  - 11.3.2.4. Market Developments
  - 11.3.2.5. Market Strategy
- 11.3.3. BD
  - 11.3.3.1. Overview
  - 11.3.3.2. Segments and Product
  - 11.3.3.3. Key Financials
  - 11.3.3.4. Market Developments
  - 11.3.3.5. Market Strategy
- 11.3.4. Cook Medical
  - 11.3.4.1. Overview
  - 11.3.4.2. Segments and Product
  - 11.3.4.3. Key Financials
  - 11.3.4.4. Market Developments
  - 11.3.4.5. Market Strategy
- 11.3.5. ConMed
  - 11.3.5.1. Overview
  - 11.3.5.2. Segments and Product
  - 11.3.5.3. Key Financials
  - 11.3.5.4. Market Developments
  - 11.3.5.5. Market Strategy
- 11.3.6. DirexGroup
  - 11.3.6.1. Overview
  - 11.3.6.2. Segments and Product
  - 11.3.6.3. Key Financials
  - 11.3.6.4. Market Developments
  - 11.3.6.5. Market Strategy
- 11.3.7. Dornier MedTech
  - 11.3.7.1. Overview
  - 11.3.7.2. Segments and Product
  - 11.3.7.3. Key Financials
  - 11.3.7.4. Market Developments
  - 11.3.7.5. Market Strategy
- 11.3.8. KARL STORZ
  - 11.3.8.1. Overview
  - 11.3.8.2. Segments and Product
  - 11.3.8.3. Key Financials
  - 11.3.8.4. Market Developments
  - 11.3.8.5. Market Strategy
- 11.3.9. Potent Optotronic
  - 11.3.9.1. Overview
  - 11.3.9.2. Segments and Product
  - 11.3.9.3. Key Financials
  - 11.3.9.4. Market Developments
  - 11.3.9.5. Market Strategy
- 11.3.10. HealthTronics
  - 11.3.10.1. Overview
  - 11.3.10.2. Segments and Product
  - 11.3.10.3. Key Financials
  - 11.3.10.4. Market Developments
  - 11.3.10.5. Market Strategy
- 11.3.11. Lumenis
  - 11.3.11.1. Overview
  - 11.3.11.2. Segments and Product
  - 11.3.11.3. Key Financials
  - 11.3.11.4. Market Developments
  - 11.3.11.5. Market Strategy
- 11.3.12. Olympus
  - 11.3.12.1. Overview
  - 11.3.12.2. Segments and Product
  - 11.3.12.3. Key Financials
  - 11.3.12.4. Market Developments
  - 11.3.12.5. Market Strategy
- 11.3.13. Richard Wolf
  - 11.3.13.1. Overview
  - 11.3.13.2. Segments and Product
  - 11.3.13.3. Key Financials
  - 11.3.13.4. Market Developments
  - 11.3.13.5. Market Strategy
- 11.3.14. Siemens Healthcare
  - 11.3.14.1. Overview
  - 11.3.14.2. Segments and Product
  - 11.3.14.3. Key Financials
  - 11.3.14.4. Market Developments
  - 11.3.14.5. Market Strategy

12. Appendix

12.1. Research Methodology
12.2. Research Assumptions
12.3. Acronyms and Abbreviations